The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy
about
Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilaritiesCCN1/CYR61: the very model of a modern matricellular protein.Potential role of Cyr61 induced degeneration of human Müller cells in diabetic retinopathy.The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration.The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident MicrogliaCCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathyConnective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 geneNew Insights into the Function of the Matricellular CCN1: an Emerging Target in Proliferative Retinopathies.Degradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina.Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy.Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).The cell-matrix interface: a possible target for treating retinal vascular related pathologies.Cyr61 activates retinal cells and prolongs photoreceptor survival in rd1 mouse model of retinitis pigmentosa.TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.A Critical Analysis of the Available In Vitro and Ex Vivo Methods to Study Retinal Angiogenesis.The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute.Abscisic acid: an antiangiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages.Analysis of CCN Protein Expression and Activities in Vasoproliferative Retinopathies.Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.The matricellular protein CCN1 in tissue injury repair.
P2860
Q26782080-1FBB3665-ED4B-4257-A4C9-E486C0D73F45Q34027926-49C96F73-AE41-49A7-8D5E-E3F32832BE67Q34351536-A693DCA3-34F7-49E5-94DB-E18196730784Q35586224-6200554F-0E3F-4C4A-A585-BE4C45A80BAFQ35618563-27824552-39BC-4801-943B-56AC1045E517Q35785287-802EFE16-CD97-4ECA-A2AE-134AFD1D7D10Q35877484-3557998F-A8DF-4E70-80E5-B8254980D29BQ36281635-5AD1629E-63E5-484C-BD1A-B05D98376A44Q36369272-66E8FC57-9B0A-4EAF-9C4A-FD8461776A0BQ36418892-5D99AEE8-AAC0-4CE2-91C4-E3E95633BBBCQ36953658-9E69D674-B2B7-41CE-A9EA-C8C13D696DB3Q37095390-53BDB688-9328-47ED-96E3-E31A090ECA4CQ37468125-92F5BECE-8264-4126-A9F6-65BFC20988BBQ37707888-4CEEB0ED-3E79-44D0-A089-8D0486B86841Q38090418-4794BE4A-E721-4CDE-A6D1-849B6CA27AD1Q39018774-E2CF93B3-26B2-4FDD-A439-E4A04B82AC9DQ40590883-72F07BCC-79BD-4C1E-92E1-6FB82384C64CQ41468154-898CE22E-C56C-40F4-B94C-0C8FD9C258A8Q45874364-5FE6FECC-1404-4218-A3D0-1C4B438D16DFQ48183508-F45F21E6-1DD4-4248-8393-48E3C098F12EQ48480284-9F84AB2F-5DA2-410A-B2BA-177E05A1D07CQ51746396-E0511B01-D7A9-4588-86C5-00D540EDBFFCQ54962838-F9143095-674F-4A51-81BB-898FC25211D3
P2860
The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The matricellular protein cyst ...... ated with ischemic retinopathy
@ast
The matricellular protein cyst ...... ated with ischemic retinopathy
@en
The matricellular protein cyst ...... ated with ischemic retinopathy
@nl
type
label
The matricellular protein cyst ...... ated with ischemic retinopathy
@ast
The matricellular protein cyst ...... ated with ischemic retinopathy
@en
The matricellular protein cyst ...... ated with ischemic retinopathy
@nl
prefLabel
The matricellular protein cyst ...... ated with ischemic retinopathy
@ast
The matricellular protein cyst ...... ated with ischemic retinopathy
@en
The matricellular protein cyst ...... ated with ischemic retinopathy
@nl
P2093
P2860
P356
P1476
The matricellular protein cyst ...... ated with ischemic retinopathy
@en
P2093
Adeel Hasan
Brahim Chaqour
Daniel Rosenbaum
Douglas Lazzaro
Hemabindu Chintala
Hyun-Seung Lee
Maria B Grant
Nataliya Pokeza
P2860
P304
P356
10.1074/JBC.M110.198689
P407
P577
2011-03-18T00:00:00Z